Effect of breastfeeding on serum osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in full term neonates

Iranian Red Crescent Medical Journal

Volumn 15, Issue 10, 2013, Pages

  Rafeey, Mandana ^a   Ghorbanihaghjo, Amir ^b   Masoumi, Fardad ^a   Alizadeh, Samira ^a   Davari Farid, Sina ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Shams General Hospital   (Iran)

Author keywords

Breast feeding; Infant formula; Osteoprotegerin; SRANKL; Tumor necrosis factor alpha (TNF )

Indexed keywords

CALCIUM; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE REMODELING; BREAST FEEDING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNITY; INFANT; MALE; NEWBORN; NUTRITIONAL VALUE;

EID: 84887281031     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: 10.5812/ircmj.7591     Document Type: Article

References (22)

1. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-beta. Immunol Cell Biol. 2000;78(1):74-79. [DOI] [PubMed]
2. Wagner CL, Taylor SN, Hollis BW. Does vitamin D make the world go 'round'? Breastfeed Med. 2008;3(4):239-50. [DOI] [PubMed]
3. Jakobsen MS, Sodemann M, Molbak K, Aaby P. Reason for termination of breastfeeding and the length of breastfeeding. Int J Epidemiol. 1996;25(1):115-21. [PubMed]
4. Vidal K, van den Broek P, Lorget F, Donnet-Hughes A. Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. Pediatr Res. 2004;55(56):1001-8. [DOI] [PubMed]
5. Tat SK, Pelletier JP, Velasco CR, Padrines M, Martel-Pelletier J. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J Med. 2009;58(1):29-40. [PubMed]
6. Bolon B, Shalhoub V, Kostenuik PJ, Campagnuolo G, Morony S, Boyle WJ, et al. Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum. 2002;46(12):3121-35. [DOI] [PubMed]
7. Yeung RS. The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. J Rheumatol.2004;31(35):844-6. [PubMed]
8. Schett G, Redlich K, Smolen JS. The role of osteoprotegerin in arthritis. Arthritis Res Ther. 2003;5(5):239-45. [DOI] [PubMed]
9. Blair JM, Zheng Y, Dunstan CR. RANK ligand. Int J Biochem Cell Biol. 2007;39(6):1077-81. [DOI] [PubMed]
10. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89(2):309-19. [PubMed]
11. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology. 1999;140(10):4451-58. [PubMed]
12. Naylor KE, Rogers A, Fraser RB, Hall V, Eastell R, Blumsohn A. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation. J Clin Endocrinol Metab. 2003;88(11):5361-65. [PubMed]
13. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165-72. [PubMed]
14. Mehta R, Petrova A. Biologically active breast milk proteins in association with very preterm delivery and stage of lactation. J Perinatol. 2011;31(1):58-62. [DOI] [PubMed]
15. Stejskal D, Bartek J, Pastorkova R, Ruzicka V, Oral I, Horalik D. Osteoprotegerin, RANK, RANKL. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001;145(2):61-64. [PubMed]
16. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther. 2007;9 Suppl 1:S1. [DOI] [PubMed]
17. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004;15(1):49-60. [PubMed]
18. Saidenberg-Kermanac'h N, Cohen-Solal M, Bessis N, De Vernejoul M-C, Boissier M-C. Role for osteoprotegerin in rheumatoid inflammation. Joint Bone Spine. 2004;71(1):9-13. [DOI]
19. Feige U. Osteoprotegerin. Ann Rheum Dis. 2001;60 Suppl 3:iii81-84. [PubMed]
20. Granot E, Golan D, Berry EM. Breast-fed and formula-fed infants do not differ in immunocompetent cell cytokine production despite differences in cell membrane fatty acid composition. Am J Clin Nutr. 2000;72(5):1202-5. [PubMed]
21. Lopez-Alarcon M, Garza C, Habicht JP, Martinez L, Pegueros V, Villalpando S. Breastfeeding attenuates reductions in energy intake induced by a mild immunologic stimulus represented by DPTH immunization: possible roles of interleukin-1beta, tumor necrosis factor-alpha and leptin. J Nutr. 2002;132(6):1293-98. [PubMed]
22. Kim MJ, Na B, No SJ, Han HS, Jeong EH, Lee W, et al. Nutritional status of vitamin D and the effect of vitamin D supplementation in Korean breast-fed infants. J Korean Med Sci. 2010;25(1):83-89. [DOI] [PubMed]